We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stay On-Target With Novel, High-Fidelity Cas9

Product News   Aug 11, 2017

 
Stay On-Target With Novel, High-Fidelity Cas9

Image Credit: Integrated DNA Technologies

FURTHER INFORMATION
 
 
 

Related Product News

ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo

Product News

ERS Genomics has announced the signing of a license agreement with Daiichi Sankyo, providing access to CRISPR/Cas9 genome editing technology intellectual property for use in its internal research and development.

READ MORE

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

READ MORE

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE